Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Respiratory Tract Diseases × Patient Reported Outcome Measures × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Neoplasms 3 Preleukemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Lymphoproliferative Disorders 2 Lymphoma 2 Lymphatic Diseases 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Leukemia 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2 Esophageal Neoplasms 2 Bone Marrow Diseases 2 Primary Myelofibrosis 1 Pathologic Complete Response 1 Neoplasms, Second Primary 1 Myeloproliferative Disorders 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Hyperthermia 1

Interventions

pembrolizumab 3 Carboplatin 3 selpercatinib 2 pralsetinib 2 durvalumab 2 Pemetrexed 2 Cisplatin 2 taletrectinib 1 sotorasib 1 repotrectinib 1 ceralasertib 1 Telescopes 1 Radiosurgery 1 Paclitaxel 1 Gemcitabine 1 Gefitinib 1 Erlotinib Hydrochloride 1 Bevacizumab 1 AZD3759 1 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡